- Sector
- Healthcare
- Industry
- Medical Devices
- IPO Date
- Apr 29, 2021
Highlights
- Market Cap
- $13.95M
- Enterprise Value
- -$10.24M
- EPS (TTM)
- -$0.64
- Total Revenue (TTM)
- $234.00K
- Gross Profit (TTM)
- -$453.00K
- EBITDA (TTM)
- -$17.42M
- Year Range
- $0.36 - $1.89
- Target Price
- $6.00
- ROA (TTM)
- -77.49%
- ROE (TTM)
- -227.43%
- Avg. Volume (1M)
- 342K
- Avg. Volume Value (1M)
- $246.18K
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
COCH Performance Chart
Envoy Medical Inc. (COCH) is up 1.4% since the beginning of the year. At $1 per share, COCH is trading 64.5% below its 52-week high of $2. Investors who bought $1,000 worth of COCH shares 5 years ago would now be looking at an investment worth $70.
Loading charts...
Compare this symbol against anything
Returns By Period
Envoy Medical Inc. (COCH) has returned 1.44% so far this year and -53.59% over the past 12 months.
Envoy Medical Inc.
- 1D
- 0.62%
- 1M
- -10.82%
- 6M
- 3.19%
- YTD
- 1.44%
- 1Y
- -53.59%
- 3Y*
- -59.78%
- 5Y*
- -41.33%
- 10Y*
- —
- ALL TIME*
- -39.93%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
COCH Monthly Returns History
Based on dividend-adjusted daily data since Apr 29, 2021, COCH's average daily return is +0.06%, while the average monthly return is +1.37%. At this rate, an investment would double in approximately 4.2 years.
Historically, 55% of months were positive and 45% were negative. The best month was Feb 2024 with a return of +306.0%, while the worst month was Oct 2023 at -82.6%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 3 months.
On a daily basis, COCH closed higher 39% of trading days. The best single day was Feb 28, 2024 with a return of +183.1%, while the worst single day was Oct 8, 2025 at -41.5%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.69% | 11.45% | -8.17% | 2.24% | 3.75% | 12.26% | -15.33% | 1.44% | |||||
| 2025 | 16.08% | -17.47% | -5.11% | 9.23% | 7.10% | -6.63% | 2.82% | -15.76% | -36.93% | 3.78% | 4.25% | -21.22% | -53.77% |
| 2024 | -35.93% | 306.03% | -16.77% | 8.42% | -44.24% | -0.42% | -9.32% | 41.12% | 7.62% | -18.46% | -13.96% | -37.28% | -21.02% |
| 2023 | 0.60% | -1.09% | 0.80% | -0.30% | 0.90% | 1.29% | 0.68% | 0.87% | -32.55% | -82.61% | 84.41% | -19.53% | -81.93% |
| 2022 | -0.51% | 0.31% | 0.51% | 0.31% | -0.31% | 0.31% | 0.20% | 0.10% | -0.10% | 0.92% | 0.71% | 0.40% | 2.87% |
| 2021 | -0.10% | -0.72% | 0.54% | -0.84% | 0.21% | 0.43% | 0.29% | -0.00% | 0.00% | -0.20% |
Benchmark Metrics
Envoy Medical Inc. has an annualized alpha of 14.36%, beta of 0.17, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since April 29, 2021.
- This stock participated in 227.30% of S&P 500 Index downside but only 27.38% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.17 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 14.36%
- Beta
- 0.17
- R²
- 0.00
- Upside Capture
- 27.38%
- Downside Capture
- 227.30%
Return for Risk
Risk / Return Rank
COCH ranks 28 for risk / return — above 28% of stocks peers on PortfoliosLab. Its historical combined result is below the peer median.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Envoy Medical Inc. (COCH) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| COCH | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.78 | ||
| Sortino ratioReturn per unit of downside risk | -1.78 | ||
| Omega ratioGain probability vs. loss probability | 1.03 | 1.25 | -0.23 |
| Calmar ratioReturn relative to maximum drawdown | -0.72 | 2.00 | -2.72 |
| Martin ratioReturn relative to average drawdown | -1.06 | 8.49 | -9.55 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Envoy Medical Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Envoy Medical Inc. was 96.29%, occurring on Feb 10, 2026. The portfolio has not yet recovered.
The current Envoy Medical Inc. drawdown is 93.61%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-96.29%Feb 2026 | 2y 4mo | — | 2y 10moSep 2023 - now | — |
-2.14%Jun 2021 | 7d | 6mo 11d | 6mo 18dMay 2021 - Dec 2021 | — |
-1.73%Jan 2022 | 1mo 19d | 8mo 11d | 10moDec 2021 - Oct 2022 | Bear market2022 |
-1.59%Mar 2023 | 1mo 3d | 1mo 28d | 3mo 1dFeb 2023 - May 2023 | — |
-1.34%Jul 2023 | 11d | 1mo 20d | 2mo 1dJul 2023 - Sep 2023 | — |
Drawdown Indicators
| COCH | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.29% | -56.78% | -39.51% |
Max Drawdown (1Y)Largest decline over 1 year | -75.48% | -9.10% | -66.38% |
Max Drawdown (3Y)Largest decline over 3 years | -96.29% | -18.90% | -77.39% |
Max Drawdown (5Y)Largest decline over 5 years | -96.29% | -25.43% | -70.86% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -93.61% | -1.58% | -92.03% |
Average DrawdownAverage peak-to-trough decline | -45.05% | -10.70% | -34.35% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 51.23% | 2.14% | +49.09% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Envoy Medical Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Envoy Medical Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for COCH relative to other companies in the Medical Devices industry. Currently, COCH has a P/S ratio of 103.3. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for COCH in comparison with other companies in the Medical Devices industry. Currently, COCH has a P/B value of 4.5. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with COCH
Add Envoy Medical Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with COCH